US Patent 11406710 Constrained conditionally activated binding proteins
Patent 11406710 was granted and assigned to Takeda Pharmaceutical Company on August, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 7, 2018
Date of Patent
August 9, 2022
Patent Applicant
Patent Application Number
16124556
Patent Citations
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11406710 Constrained conditionally activated binding proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
